Page 1 of Clinical Trials for Triptorelin, 63 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
Comparative Validation of the Triptorelin Test for the Diagnosis of CPP in Girls
Last Updated: January 14, 2011
Condition(s): Central Precocious Puberty; Sexual Precocity
2
Active, not recruiting
Equivalence of Intramuscular (IM) Versus Subcutaneous (SC) Applications of Long Acting Pamorelin 11.25 mg
Last Updated: January 30, 2012
Condition(s): Prostate Cancer
3
Recruiting
HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer.
Last Updated: October 26, 2011
Condition(s): Breast Cancer
4
Completed
Efficacy and Safety of a Triptorelin 6-Month Formulation in Patients With Advanced Prostate Cancer
Last Updated: September 11, 2008
Condition(s): Locally Advanced or Metastatic Prostate Cancer
5
Terminated
Study to Assess the Non-inferiority of Pamorelin® 11,25mg SC Injected Versus Pamorelin® 11,25mg IM Injected in Patients Suffering From Advanced Prostate Cancer (PAMOJECT)
Last Updated: December 10, 2009
Condition(s): Prostate Cancer
6
Completed
Efficacy and Safety Study of Pamoate of Triptorelin in Children With Precocious Puberty
Last Updated: February 9, 2012
Condition(s): Precocious Puberty
7
Recruiting
Triptorelin for Ovary Protection in Childhood Onset Lupus
Last Updated: August 25, 2011
Condition(s): Systemic Lupus Erythematosus
8
Recruiting
Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate Cancer
Last Updated: April 30, 2012
Condition(s): Prostate Cancer
9
Completed
Half-Dose Depot Triptorelin Versus Reduced-Dose Daily Buserelin
Last Updated: April 17, 2007
Condition(s): Infertility
10
Completed
Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer
Last Updated: August 7, 2010
Condition(s): Breast Cancer; Drug/Agent Toxicity by Tissue/Organ; Hormonal Changes
11
Completed
Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery
Last Updated: July 23, 2011
Condition(s): Breast Cancer
12
Active, not recruiting
Effects of Triptorelin Pamoate in Children With Precocious Puberty - Follow up Study
Last Updated: January 30, 2012
Condition(s): Precocious Puberty
13
Not yet recruiting
Study on Efficacy, Safety, and Pharmacokinetics of Triptorelin 6-month Formulation in Patients With Central Precocious Puberty
Last Updated: November 8, 2011
Condition(s): Central Precocious Puberty
14
Terminated
Study to Evaluate a Subcutaneous Four Months Sustained-Release Formulation of Triptorelin in Patients With Prostate Cancer
Last Updated: November 15, 2007
Condition(s): Prostate Cancer
15
Completed
Effect of Triptorelin (Decapeptyl®) 22.5 mg on Two Biomarkers in Patients With Advanced Prostate Cancer
Last Updated: November 29, 2011
Condition(s): Prostate Cancer
16
Active, not recruiting
Efficiency of Gonadotropin-releasing Hormone (GnRH) Agonist in Preventing Chemotherapy Induced Ovarian Failure
Last Updated: July 30, 2010
Condition(s): Ovarian Function Restoration After Chemotherapy for Lymphoma
17
Recruiting
Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer
Last Updated: February 18, 2011
Condition(s): Prostate Cancer
18
Recruiting
Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer
Last Updated: February 6, 2009
Condition(s): Prostate Cancer
19
Completed
A Study to Assess the Efficacy and Safety of Ganirelix (Orgalutran®) Treatment in Chinese Women Undergoing Controlled Ovarian Stimulation for in Vitro Fertilization (IVF) or Intra Cytoplasmatic Sperm Injection (ICSI) (Study 38651)(COMPLETED)(P05703)
Last Updated: February 11, 2010
Condition(s): Controlled Ovarian Stimulation
20
Recruiting
Endometrial Receptivity After GnRH Agonist Triggering
Last Updated: December 28, 2011
Condition(s): Ovarian Hyperstimulation Syndrome

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Triptorelin

Page 1 of Clinical Trials for Triptorelin, 63 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About